How large is the stool softener market, and what is its growth trajectory?
The stool softener market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to the aging population, dietary changes, increased public awareness about digestive health, increased surgical procedures, and lack of physical activity.
The stool softener market size is expected to see strong growth in the next few years. It will grow to $2.43 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing cases of gastrointestinal conditions, higher healthcare spending, increasing marketing efforts by pharmaceutical companies, the shift of many stool softeners from prescription-only to over-the-counter status, and chronic disease prevalence. Major trends in the forecast period include improvements in medical diagnostics and treatments, the development and approval of more effective stool softener formulations, innovations in formulation technology, the development of personalized stool softener products, and the development of effervescent stool softener tablets.
Get Your Free Sample of The Global Stool Softener Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16548&type=smp
What are the key forces behind the stool softener market’s growth in recent years?
The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the stool softener market going forward. Gastrointestinal disorders refer to any condition or disease that affects the gastrointestinal tract, which includes the mouth, esophagus, stomach, small intestine, large intestine, and anus. The increasing prevalence of gastrointestinal disorders is attributed to various factors, including lifestyle changes such as poor diet, lack of exercise, and stress. Stool softeners help alleviate gastrointestinal disorders by making stools easier to pass, thereby preventing constipation and reducing strain during bowel movements. For instance, in 2023, according to Crohn’s and Colitis Canada, a Canada-based non-profit organization, the number of people in Canada with IBD is increasing rapidly, from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (1 every 48 minutes), and by 2035, this will rise to 14,000 (1 every 38 minutes). Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the stool softener market.
What are the major segments of the stool softener market?
The stool softener market covered in this report is segmented –
1) By Type: Liquid, Softgel Capsule
2) By Form: Medicines, Procedures
3) By Mode Of Administration: Oral, Rectal
4) By Availability: Over-The-Counter, Prescription
5) By End Use: Hospitals, Clinics, Home Care, Other End Uses
Subsegments:
1) By Liquid: Oral Solutions, Syrups, Drops
2) By Softgel Capsule: Standard Softgel Capsules, Enhanced Or High-Dosage Softgel Capsules
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/stool-softener-global-market-report
Which companies dominate the stool softener market?
Major companies operating in the stool softener market are F. Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca Plc., Abbott Laboratories Inc., Takeda Pharmaceutical Company Ltd., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Solvay S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Purdue Pharma L.P., Mallinckrodt Plc, Aristo Pharma GmbH, Raptakos Brett Co. Ltd., Unipex Group Inc., Chemo Biological, Angiolife Healthcare Pvt. Ltd., Iscon Life Sciences, Starmed Pvt. Ltd., Phaedrus Ltd., Stadmed Pvt. Ltd., Avrio Health L.P., Healwell, Velnex Medicare, Sanify Healthcare Pvt. Ltd.
What major trends will shape the stool softener market during the forecast period?
Major companies operating in the stool softener market are focusing on developing innovative products such as ayurvedic liquid laxative to provide natural and gentle relief options for consumers. An Ayurvedic liquid laxative is a natural, herbal-based formulation designed to relieve constipation by promoting gentle bowel movements. It combines traditional Ayurvedic ingredients known for their digestive benefits to support overall gut health. For instance, in December 2023, Lupin Limited, an India-based pharmaceutical company launched Softovac Liquifibre. This product is a 100% ayurvedic liquid laxative that combines Isabgol fiber with natural ingredients such as Sonamukhi and Harad, providing effective relief from constipation. This product is clinically validated for safety and efficacy, ensuring it is gentle, non-habit-forming, and suitable for daily use, even for diabetics due to its sugar-free formulation.
What are the key regional dynamics of the stool softener market, and which region leads in market share?
North America was the largest region in the stool softener market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stool softener market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Stool Softener Market Report 2025 Offer?
The stool softener market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
A stool softener is a type of laxative that helps soften stool by increasing the amount of water in the intestines, making it easier to pass without straining. It is used for treating mild constipation and is often recommended for people who should avoid straining during bowel movements, such as after surgery. Stool softeners are used short-term to relieve occasional constipation and are available over-the-counter (OTC) or by prescription.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16548
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
